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Abstract
Rapid advances in genome sequencing and gene expression microarray technologies are providing unprecedented opportunities
to identify speciﬁc genes involved in complex biological processes, such as development, signal transduction, and disease. The vast
amount of data generated by these technologies has presented new challenges in bioinformatics. To help organize and interpret
microarray data, new and eﬃcient computational methods are needed to: (1) distinguish accurately between diﬀerent biological or
clinical categories (e.g., malignant vs. benign), and (2) identify speciﬁc genes that play a role in determining those categories. Here we
present a novel and simple method that exhaustively scans microarray data for unambiguous gene expression patterns. Such
patterns of data can be used as the basis for classiﬁcation into biological or clinical categories. The method, termed the Charac-
teristic Attribute Organization System (CAOS), is derived from fundamental precepts in systematic biology. In CAOS we deﬁne two
types of characteristic attributes (pure and private) that may exist in gene expression microarray data. We also consider additional
attributes (compound) that are composed of expression states of more than one gene that are not characteristic on their own.
CAOS was tested on three well-known cancer DNA microarray data sets for its ability to classify new microarray samples. We
found CAOS to be a highly accurate and robust class prediction technique. In addition, CAOS identiﬁed speciﬁc genes, not em-
phasized in other analyses, that may be crucial to the biology of certain types of cancer. The success of CAOS in this study has
signiﬁcant implications for basic research and the future development of reliable methods for clinical diagnostic tools.
 2002 Elsevier Science (USA). All rights reserved.
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1. Introduction
Gene expression proﬁles generated with DNA mi-
croarray technology yield immense quantities of data.
Access to the wealth of valuable information hidden
within these data requires computationally intensive
methodologies for organization and interpretation of
results.
Current methods used to search for previously un-
recognized order (‘‘class discovery’’ sensu Golub et al.
[23]) in microarray data sets most commonly rely on
measurements of overall similarity or correlation to ﬁnd
natural groupings of microarray samples and genes
[1,2,6,16,21,23,44]. Such techniques can organize genes
or microarray samples either as a partitioned constel-
lation of unrelated groups [6,41,44] or as a hierarchy of
related individuals and groups [1,2,16,21]. The latter has
often been depicted as a branching diagram or tree by
using established methods from phylogenetics and sys-
tematic biology We recently argued for the use of other
systematic/cladistic methods of hierarchic organization
based on analysis of discrete attributes as an alternative
to measurements of overall similarity [36].
Another important objective of microarray analysis is
to identify particular gene expression patterns that may
contribute to the biology of a class. This goal has been
Journal of Biomedical Informatics 35 (2002) 111–122
www.academicpress.com
*Corresponding author. Fax: 1-212-769-5277.
E-mail address: desalle@amnh.org (R. DeSalle).
1 These authors contributed equally to this work.
1532-0464/02/$ - see front matter  2002 Elsevier Science (USA). All rights reserved.
PII: S1532 -0464 (02 )00504-X
pursued using multidimensional scaling plot analysis [7],
correlation with idealized expression patterns [23], cou-
pled two-way analysis [21], measurements of misclassi-
ﬁcation potential [5], artiﬁcial neural networks [26],
support vector machines [9,50], principle component
analysis/singular value decomposition [3,11,37], and
correspondence analysis [19]. Due to the high dimen-
sionality of the data, eﬀorts have been made to reduce
the computational intensity of analyses using either
heuristic algorithms that optimize classiﬁcation [50] or
by using statistical projection techniques to reduce the
total number of variables in the data (e.g., Principle
Component Analysis/Singular Value Decomposition
[3,37], Correspondence Analysis [19]). Gene expression
patterns identiﬁed by these methods serve a double
purpose. First, they provide starting points for future
research that aims to elucidate relevant molecular
pathways. Second, they can be used as diagnostic pre-
dictors to classify new microarray samples.
Here we present a novel, computationally tractable,
and exhaustive approach to interpreting gene expression
microarray data that is based on the simple concept that
members of a particular group may share attributes that
do not occur in other groups. This method, designated
the Characteristic Attribute Organization System
(CAOS), searches an entire data set for all discrete gene
features that unambiguously characterize individual
microarray samples. CAOS is based on the fundamental
idea of parsimony—i.e., the best answer is the one that
accounts for all of the data while making the least
number of additional (ad hoc) hypotheses. A closely
related technique from systematic biology, Population
Aggregation Analysis (PAA; [12]), is used in conserva-
tion biology to ﬁnd patterns of discrete features (attri-
butes) that unambiguously distinguish all individuals in
a population from members of other groups. Gene ex-
pression levels can be viewed as the attributes of indi-
vidual DNA microarray samples. We designed CAOS to
search large microarray data sets for ‘‘characteristic at-
tributes’’ that are then used as diagnostic standards to
classify new microarray samples.
We show that the characteristic attributes derived
from even a very simple version of CAOS can be used as
an accurate and robust diagnostic tool for class predic-
tion. Analysis of three well-known cancer microarray
data sets reveals the potential for CAOS to be a pow-
erful tool. Additionally, CAOS identiﬁed potentially
relevant genes with diagnostic expression patterns that
were not emphasized by other techniques.
2. Materials and methods
Initial classiﬁcation of microarray data sets. The mi-
croarray data sets used to test CAOS have previously
been described [2,7,23] (Table 1). The Bittner et al. [7]
data set was grouped into the two classes of malignant
melanomas (major and minor) elucidated in that study
by phenetic clustering techniques. The Golub et al. [23]
data set was divided ﬁrst into acute myeloid leukemia
(AML) and acute lymphoblastic leukemia (ALL) as
determined in that study. The Alon et al. [2] data were
separated into normal and colon cancer.
Data matrices and recoding. Continuous gene ex-
pression values in the microarray data matrices were
recoded as discrete values using a binning approach
[30,36]. A bin is deﬁned as a range of scaled intensity
values into which each data point could fall. We desig-
nated two bins separated by the median value for a
particular gene over all microarray samples. Values
above the median were recoded as the value ‘‘1;’’ and
those below, as ‘‘0.’’ Other more complex binning
strategies are possible [30], and we are currently inves-
tigating various techniques, as well as estimations of the
amount of data that is lost during the binning process.
Characteristic attributes. The new matrix of recoded
data was then searched for binned gene expression states
(‘‘attributes’’) that unambiguously distinguished mem-
bers of diﬀerent classes from each other (‘‘characteristic
attributes’’). Characteristic attributes are deﬁned as
binned expression values (i.e., 1 or 0) for a particular
gene that occur in microarray samples of one class and
are never observed outside that class. ‘‘Pure’’ charac-
teristic attributes are found in every member of a group;
‘‘private’’ characteristic attributes are found only in
some members of a group. Using CAOS-ag99 (‘‘CAOS-
aggregator 1999’’), an application written in C++, each
gene was evaluated on the basis of its gene expression
states as a possible characteristic attribute. CAOS-ag99
ﬁnds and records binned expression values that only
appear in one of the two classes and assigns such char-
acteristic attributes a weighted rank (Rw) (Fig. 2A). Rw is
the ratio of the number of samples in the data set that
exhibit the characteristic attribute (SE) to the total
Table 1
Numbers of characteristic attributes for the three data sets
Dataset Bittner et al. (275 genes) Alon et al. (2000 genes) Golub et al. (7129 genes)
Groups Minor [12] Major [19] Cancer [40] Normal [22] ALL [27] AML [11]
Pure Private Pure Private Pure Private Pure Private Pure Private Pure Private
Simple 0 75 0 5 0 84 0 11 1 885 1 80
Compound 33 6028 12 1529 0 64,416 2 17,560 602 1,592,211 1680 177,127
112 I.N. Sarkar et al. / Journal of Biomedical Informatics 35 (2002) 111–122
number of samples in the group (SG) (Eq. (1)). This
value is then scaled to 10 so that it is comparable to
other ranking systems. An Rw of 10 indicates a pure
characteristic attribute, whereas values less than 10 in-
dicate private characteristic attributes with diﬀerent
relative abundances
Rw ¼ SESG
 
 10: ð1Þ
CAOS-ag99 also searches for combinations of bin
values that occur together only in members of a prede-
ﬁned group or class (‘‘compound’’ characteristic attri-
butes). In this procedure genes are combined in the
matrix to create a new set of attributes that is the
combination of the bin values coded as 00, 01,10, and
11. The theoretical upper limit (U) for the number of
compound characteristic attributes (Eq. (2)) is calcu-
lated from the total number of genes in the microarray
(N) and the order (D) of the compound attribute, which
is deﬁned as the integer number of genes that are com-
bined to make the compound attribute
U ¼ N !
D!ðN  DÞ! such that; D > Nð2Þ: ð2Þ
By deﬁnition, the combination of any simple charac-
teristic attribute with any other attribute will always
yield a compound characteristic attribute. Because such
compound attributes yield no new information, we
excluded them from this analysis by requiring that each
compound characteristic attribute be composed of only
those attributes that were not characteristic at any
lower order. For example, all simple (ﬁrst-order com-
pound) characteristic attributes were excluded from the
identiﬁcation of second-order compound attributes.
Weighted ranks (Rw) were determined for compound
attributes with the same algorithm used for simple at-
tributes.
Class prediction/voting. Characteristic attributes (pure
and private; simple and compound) identiﬁed by CAOS-
ag99 were then used to create a set of diagnostic rules to
classify microarray samples (Fig. 2B). The diagnostic
rule set was constructed and implemented using CAOS-
rr01 (Characteristic Attribute Organization System—
rule reader 2001’’), a script written in Perl5. The script
ﬁrst tests unclassiﬁed samples for the presence or ab-
sence of the listed characteristic attributes.
CAOS-rr01 then sums the Rw values for every char-
acteristic attribute found in the unclassiﬁed sample
(foundRw). This sum is compared to the sum of all
possible Rw values (possibleRw) for each particular
group (G) to eliminate bias towards groups with greater
numbers of characteristic attributes. This ratio, A, is the
adjusted score (Eq. (3))
AG ¼
P
foundRwP
possibleRw
: ð3Þ
The unclassiﬁed sample is classiﬁed into the group for
which the A score is higher. When the A score is within
5% of the other score(s) (e.g., A1=A2 < 0:95), the classi-
ﬁcation is regarded as ambiguous.
Robustness. To test the robustness of CAOS, we
used a Leave-One-Out-Cross-Validation (LOOCV)
jackniﬁng technique similar to that presented by Go-
lub et al. [23]. A single microarray sample was re-
moved from the data set, and the remaining samples
were searched with CAOS-ag99 to identify character-
istic attributes. Using diagnostic rules generated by
CAOS-rr01, we attempted to classify the withheld
sample. This procedure was repeated for every sample
in the data set, and the result was monitored for
correct or incorrect classiﬁcation.
Standard measurements of classiﬁcation were calcu-
lated for each iteration. True Positive (TP) values were
calculated as the number of samples correctly assigned
to the group to which each belongs (e.g., if examining
AML, AML sample being classiﬁed as AML). True
Negative (TN) values were the number of samples cor-
rectly identiﬁed as not belonging to the group including
those classiﬁed as ambiguous (e.g., if examining AML,
the number of ALL classiﬁed as ALL). False Positive
(FP) values were the number of samples incorrectly as-
signed to a group (e.g., if examining AML, ALL being
classiﬁed as AML). False Negative (FN) values were the
number of samples that were incorrectly placed outside
of the group including those classiﬁed as ambiguous
(e.g., if examining AML, AML being classiﬁed as ALL).
The overall accuracy of CAOS-based classiﬁcations
was calculated as the total number of correctly classiﬁed
samples (TPs for both group 1 and 2) divided by the total
number of samples including those regarded as ambigu-
ous. Sensitivity is TP/(TP+FN). Speciﬁcity is TN/
(TN+FP). The ambiguity of all the classiﬁcations was
calculated as the percentage of classiﬁcations that were
not classiﬁable (either when A1=A2 < 0:95 or when
A1 ¼ A2 ¼ 0).
An important feature of CAOS is that all possible
characteristic attributes are considered regardless of
rank. Even low-ranking characteristic attributes may be
needed to identify members of subsets with few repre-
sentatives in the original (training) data set. Ideally all
characteristic attributes would be used, but we found
that we could increase the accuracy of diagnosis in some
cases by excluding some characteristic attributes, sug-
gesting insigniﬁcant variation in the sample data—i.e.,
‘‘noise.’’ To attempt to ﬁlter out noise while retaining
valuable low ranking private characteristic attributes,
we introduced the concept of corroboration, which
simply requires a characteristic attribute to be supported
by its appearance in a speciﬁed number of other samples
before it is included in the diagnostic rules. The number
of samples required to corroborate a characteristic
attribute (corroboration coeﬃcient; Crob) can be
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increased to create very well corroborated but poten-
tially less sensitive diagnostic rule sets, or decreased to
create potentially noisy (perhaps nonspeciﬁc) rule sets
that should be more sensitive.
To maximize sensitivity with the least amount of
corroboration, we repeated the LOOCV jackniﬁng
procedure while excluding characteristic attributes that
fell below a series of ‘‘corroboration rank cutoﬀs.’’
Corroboration rank cutoﬀs (CRC) were determined by
adjusting the corroboration coeﬃcient (Crob) according
to the number of samples in a particular class (SG) (Eq.
(4))
CRC ¼ Crob 10
SG
 
: ð4Þ
Crob was varied as an integer from 1 to q 1
(where q is the number of samples in the smaller
class). The ‘‘optimal corroboration rank cutoﬀ values’’
(OCRC) were then determined as the value at which
the most microarray samples were accurately diag-
nosed with the least amount of corroboration (lowest
Crob) required.
Xiong et al. [50] have recently demonstrated that
more versatile heuristic algorithms can be used to
maximize classiﬁcation accuracy. Signiﬁcantly, they
have reported classiﬁcation accuracy levels higher than
those reported here for the Alon et al. data set. We are
currently exploring similar optimizing algorithms that
could be applied to CAOS classiﬁcation.
Receiver Operating Characteristic (ROC) curves.
ROC curves were determined from the eﬃcacy of
CAOS-based analysis on the entire data set using
varying training set sizes. Training set sizes were 3, q=2,
and q 1 samples from each group (q is the number of
elements in the smaller group). We performed 200 rep-
licates at each training set size value. The speciﬁcity and
sensitivity of each test was determined and plotted for
each replicate. We generated ROC curves using the
SPSS statistical package [42].
Testing an independent data set. The Golub et al.
training data set was used to determine a set of char-
acteristic attributes to distinguish between acute myeloid
leukemia (AML) and acute lymphoblastic leukemia
(ALL). The LOOCV jackkniﬁng technique, as described
above, was performed at each corroboration coeﬃcient.
The optimal corroboration coeﬃcient (OCRC) was de-
termined as above to exclude non-optimal characteristic
attributes. CAOS-rr01 was then used to classify an in-
dependent set of 34 samples as provided in the supple-
mentary data of Golub et al.
Comparison of potentially biologically relevant attri-
butes. We compared our CAOS-based rankings to the
prediction strengths of genes identiﬁed by the three
cancer studies analyzed here. The ‘‘prediction strengths’’
from the Golub et al. and Alon et al. data sets were
normalized to a scale of 0–10. To determine the statis-
tical similarity of the sets of ranked genes, we used a
Wilcoxon Signed Rank Test, which evaluates the sta-
tistical signiﬁcance of the diﬀerence between two or-
dered lists [42].
3. Results
3.1. Characteristic attributes—pure, private, simple, and
compound
Individual members of any groupmay share attributes
that unambiguously distinguish them from members of
other groups. We refer to these attributes as ‘‘character-
istic attributes.’’ Here we consider the scaled intensities of
hybridization (i.e., gene expression levels) as the attributes
of individual microarrays. Our approach deﬁnes distinct
patterns of gene expression states that unambiguously
characterize members of a speciﬁc group.
We deﬁned two diﬀerent types of characteristic at-
tributes: ‘‘pure’’ and ‘‘private’’ (Fig. 1). Pure character-
istic attributes are present in every member of a speciﬁed
class and absent from every individual outside the class
(e.g., a gene that is on in every cancerous cell and oﬀ in
every normal cell). These are the most sought after genes
in any method. Because such genes are extremely rare,
we also deﬁned private characteristic attributes, which
Fig. 1. Four types of characteristic attributes. Characteristic attributes
are depicted in a hypothetical alignment of binned microarray data.
Each row represents a single microarray sample. Each column repre-
sents a particular gene. Simple attributes are taken from only one
column. Simple Pure (sPu) characteristic attributes are binned gene
expression values (0 or 1) that are found in all members of one group
and never outside that group. Simple Private (sPr) characteristic at-
tributes are found in some members of one group and never outside
that group. Compound characteristic attributes are found by assessing
each possible combination of two genes. Compound Pure (cPu)
characteristics are combinations of gene expression values (11, 01, 10,
or 00) that are found in all members of a group and are never found
together in samples outside that group. Compound Private (cPr)
characteristic attributes are combinations of gene expression values
that are found in some samples in one group and never outside that
group.
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are present in some, but not all, members of a class, and
absent from every individual outside that class. If a
sample has either type of characteristic attribute it can
be unambiguously classiﬁed. Our analysis discards at-
tributes that occur in both groups.
We diﬀerentiated between ‘‘simple’’ characteristic
attributes and ‘‘compound’’ characteristic attributes
(Fig. 1). Compound characteristic attributes are formed
when two or more simple attributes are associated with
each other only in one group and never outside that
group. This idea expands the concept of microarray
attributes to include combinations of gene expression
states. It allows for the inclusion of a new class of
characteristic attributes composed of multiple attributes
that alone are not characteristic—i.e., we excluded any
attributes found to be individually characteristic from
participating in compound characteristic attributes. In
this preliminary study, we limited our analysis to
compound characteristic attributes formed from two
individual attributes only. In theory, compound char-
acteristic attributes could consist of three or more
attributes. Like simple characteristic attributes, com-
pound characteristic attributes can be either ‘‘pure’’ or
‘‘private.’’
We wrote a computer application (CAOS-ag99) that
searches microarray data sets for characteristic attri-
butes and assigns ranks based on the percentage of mi-
croarray samples that share that particular attribute.
Three well-studied cancer DNA microarray data sets
were used to test the eﬀectiveness of CAOS. CAOS-ag99
identiﬁed all the types of characteristic attributes that we
deﬁned. All applications were built and executed on a
Dual-Processor 400MHz Sun Enterprise 3000 Server
with 1GB of System Memory running SunOS 5.8. The
application was able to perform exhaustive searches for
simple characteristic attributes in approximately 1min
(Bittner et al. data set) to about 10min (Golub et al.
data set). Searches for compound attributes varied from
10min (Bittner et al, data set) to approximately 3 h
(Golub, et al. data set).
While simple pure characteristic attributes are rare or
absent, compound pure characteristic attributes are
Fig. 3. Distribution of ranked genes for both simple (A) and compound (B) characteristic attributes. The histograms plot rank values (Rw) for each
characteristic attribute in each group, in decreasing order. Horizontal lines indicate the optimal corroboration rank cutoﬀ values (OCRC).
Fig. 2. CAOS is a two-step process. Panel A: Finding characteristic
attributes in microarray data. Data are shown as red and green spots
representative of increased expression or decreased expression results,
respectively. These data are ﬁrst grouped using some a priori criterion.
Next, characteristic attributes are determined by CAOS-ag99. These
characteristic attributes form the basis for a set of diagnostic rules.
Panel B: Diagnostic rules can then be used to classify novel samples by
a voting process in which the new sample is placed in the group for
which it has the highest vote total.
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relatively frequent (Table 1). CAOS identiﬁed com-
pound pure characteristic attributes in at least one
group from each of the three data sets, whereas simple
pure characteristic attributes were found only in the
Golub et al. data set. In addition, rank distributions and
the total number of characteristic attributes were dif-
ferent from one group to another and from one data set
to another (Fig. 3). Such diﬀerences would be expected
when comparing groups with diﬀering levels of homo-
geneity. For instance, heterogeneous groupings com-
posed of distinct subgroups would be expected to yield
many private characteristic attributes with few pure
characteristic attributes. Diﬀerences in the total number
of characteristic attributes would be expected depending
on the overall similarity of the groups being compared.
Two very similar types of cancer might yield few dis-
tinguishing characteristic attributes, whereas two very
diﬀerent types may yield many.
3.2. Classiﬁcation with characteristic attributes
We hypothesized that an optimal classiﬁcation
scheme would be based on the least ambiguous set of
criteria possible. Characteristic attributes, because they
represent unambiguous distributions of attribute data,
should be ideal as the basis for such a classiﬁer. By
deﬁnition, rules derived from the training set will always
be 100% speciﬁc with regard to the samples in the
training set—i.e., they will never misclassify a sample.
Also, if at least one characteristic attribute exists for
every sample, then CAOS-based diagnosis will always
result in the classiﬁcation of all samples in the training
set with 100% sensitivity. This was the case in all three
data sets studied here. Importantly, diagnostic rules
from compound characteristic attributes alone and the
combination of simple and compound characteristic
attributes always classiﬁed samples from the training set
with 100% sensitivity. Likewise, rules from simple
characteristic attributes alone were able to classify with
100% sensitivity in the Golub et al. and Bittner et al.
data sets. In the Alon et al. data set, some samples
contained no simple characteristic attributes at all, giv-
ing a sensitivity of 94%. These samples relied entirely on
compound characteristics for classiﬁcation.
To test the robustness of CAOS-based diagnosis and
its eﬃcacy on samples drawn from outside the training
data set, we used a LOOCV jackkniﬁng technique
(Table 2) and found very high levels of accuracy. By
excluding characteristic attributes with ranks below
certain optimized thresholds (OCRCs), we found that
we could increase the overall accuracy of diagnosis. To
ﬁnd the optimal corroboration rank cutoﬀ value, we did
multiple LOOCV replicates and varied the number of
samples that were required to possess, and therefore
corroborate, a particular characteristic attribute in order
for it to be kept in the set of diagnostic rules. Corrob-
oration rank cutoﬀs were optimized for each data set by
maximizing accuracy and then minimizing the amount
of corroboration and ambiguous classiﬁcation (Fig. 3).
We tested the diagnostic accuracy of CAOS-based
classiﬁcation using the independent sample test set pre-
sented in Golub et al. [23]. In that study, the prediction
technique conﬁdently classiﬁed 29 of 34 samples, re-
sulting in 85% sensitivity with 100% speciﬁcity. In
comparison, CAOS-based diagnostics were able to
classify all 34 samples, to yield 100% sensitivity with
100% speciﬁcity.
We hypothesized that the speciﬁcity and sensitivity of
CAOS-based diagnosis would increase as more samples
were included in training sets to construct diagnostic
rules. To test this idea, we used a bootstrapping tech-
nique to gauge the success of classiﬁcation in each data
set using randomly chosen training subsets of diﬀerent
sizes. ROC curves showed a consistent trend towards
higher speciﬁcity and sensitivity with larger initial data
training sets (Fig. 4). These results indicate that diag-
nostic rule sets can be improved by increasing the size of
the training set. Furthermore, the results suggest that
use of very large training sets will allow CAOS to create
highly reliable diagnostic rule sets for clinical diagnosis.
Fig. 4. Eﬀect of training set size on sensitivity and speciﬁcity. Shown
are ROC curves that were generated, at three diﬀerent sample sizes,
using a bootstrap methodology (see Section 2). The positive group for
sensitivity and speciﬁcity calculations is noted in parentheses. Simple
characteristic attributes alone and simple and compound characteristic
attributes in combination were used for classiﬁcation of each of the
data sets. Note that there is a general tendency toward higher sensi-
tivity and speciﬁcity as the training sample size is increased.
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Because of the simplicity of this algorithm, such analysis
is easy to accomplish.
3.3. Comparison of gene identiﬁcation and ranking
Does CAOS identify genes that are missed by other
techniques? To address this question, we compared rank
distributions of the characteristic genes and expression
levels found by CAOS to those found by other tech-
niques (Fig. 5). In every case, rank distributions were
clearly diﬀerent. Several genes ranked very low by other
techniques were given very high ranks by CAOS and
vice versa. A Wilcoxon Signed Rank Test validated this
disparity as statistically signiﬁcant (Fig. 5).
Because characteristic attributes are by deﬁnition un-
ique to a category, the genes they represent in microarray
samples may have functional relevance to the nature of
the category. We examined our highest ranked genes to
determine if there was any correlation with the cancers
being diagnosed. Several of the genes are known or
suggested to play a role in cancer biology including
CD45, tenascin C, Annexin II, MART-1, IL-6, NCAM,
4-Ptase II, DGCR6, CD9, and INF-a among others (see
below). Many of the high-ranking characteristic attri-
butes are ESTs from genes whose functions are unknown.
4. Discussion
Characteristic attributes are commonly used in
medical diagnosis. A patients speciﬁc signs and symp-
toms, or combinations thereof, are routinely evaluated
to identify a disease and determine prognosis. Micro-
array data present an opportunity to expand this type of
analysis to include many gene expression events as signs
of a disease. In fact, use of microarray technology is
being seriously considered as a viable option for patient
diagnosis [38].
We developed CAOS to: (1) create diagnostic rules
for classiﬁcation, and (2) highlight particular features
with potential biological relevance. CAOS is an eﬃ-
cient, automated, and exhaustive technique that ex-
amines large amounts of data to identify characteristic
attributes of a speciﬁc group and then uses them to
Fig. 5. Comparison of genes ranked by CAOS and other methods. Graphs depict each ranked gene from the three previous studies [2,7,23] in order
from highest to lowest rank (blue) compared to the rank of the same genes found using CAOS (pink). The z-score and p-value, as reported by a
Wilcoxon Signed Rank Test, are shown in the boxes.
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classify data from new samples (Fig. 2). We applied
this technique to cancer gene expression data and
found that it performed as an accurate and robust
method for classiﬁcation and analysis. In addition, we
found that CAOS consistently identiﬁed genes of
known importance and others of potential relevance to
malignancies.
4.1. Development of the CAOS idea
CAOS classiﬁcation is based on the idea that a new
sample can be assigned to the group in which it causes
the least amount of disruption to the observed pattern of
unambiguously distributed attributes. Consider an un-
known sample S that could be classiﬁed into group A or
group B. We perform CAOS analysis on A vs. B and
ﬁnd that there is a set of characteristic attributes that
can classify all members of A and B with 100% sensi-
tivity and speciﬁcity. If we then add S to A and rerun the
CAOS analysis, many characteristic attributes are de-
leted and several others emerge. If we add S to B and
rerun the CAOS analysis only a few characteristic at-
tributes are added and deleted. Therefore, it is least
disruptive, or least contradictory, to place S in B. The
fundamental basis of the CAOS classiﬁcation operation
presented in this paper is to place a new sample in the
group with which it shares more well corroborated
characteristic attributes. CAOS-based classiﬁcation at-
tempts to minimize the number of ad hoc hypotheses
required to place the sequence in one of the two
groups—i.e., it is the most parsimonious classiﬁcation.
Thus, CAOS based analysis can be supported, exam-
ined, and criticized, by the logic, techniques, and rich
literature that support parsimony analysis in systematic
biology [17]. Furthermore, CAOS also serves as a
starting point for introducing other techniques that have
been tested on discrete attributes, such as Maximum
Likelihood [20] and Bayesian analysis [28], to micro-
array studies.
The use of attribute data is routine in evolutionary
and conservation biology [10,12,22,46]. Davis and Nix-
ons [12] PAA method focuses on ﬁnding characteristic
attributes that distinguish one population of organisms
from another. These absolute types of characteristics are
what we term as ‘‘pure.’’ Pure characteristic attributes in
CAOS possess the strongest diagnostic potential because
they can account for every member of a group. They are
also the most obvious starting points in a search for
biological function.
We adopted the term ‘‘private’’ which is used in
population genetics to designate attributes that occur
only in one group but are not shared by all the members
of that group [4,43]. The existence of private charac-
teristic attributes in a group could signal the presence of
a subgroup whose members all possess an attribute, or it
may simply represent the loss of some constraint that
allows variation in one group and not the other. Hier-
archical systematic grouping techniques may be able to
distinguish between these two interpretations.
We have extended the idea of pure and private at-
tributes to include characteristic attributes that are
formed by combining multiple attributes (compound
characteristic attributes). Such attributes can be thought
of as associating with each other only in a certain group
or as co-varying. This linkage may be indicative of some
functional constraint or interaction between the attri-
butes.
To this end we created an application that searched
microarray data-sets, using an exhaustive algorithm that
examines each binned gene state individually (for simple
characteristic attributes) and then in pairs (for com-
pound attributes). While the application used for the
present study was not written with the intent for high-
speed, the entire analysis of all three of the data sets was
completed in less than 12 h on a Dual-Processor
400MHz Sun Enterprise 3000 Server with 1 Gigabyte of
System Memory running SunOS 5.8. This result is sig-
niﬁcant, as search algorithms and parallel processing
systems can be used to substantially increase speed, es-
pecially as no computationally intensive calculations are
required. Once the diagnostic rule sets are established, it
takes less than a minute to classify a sample.
4.2. Cancer DNA microarray data and CAOS
We expect that CAOS will be particularly eﬀective in
the classiﬁcation of cancer microarray data for the fol-
lowing reasons. First, in prognostic or diagnostic cate-
gories with large amounts of heterogeneity or
overlapping gene expression, simple characteristics may
be the most useful class predictors. Second, any set of
groupings or categories can be deﬁned for analysis,
which makes this supervised technique extremely ver-
satile and applicable both to existing medical categories
and those that are newly discovered. Third, CAOS al-
lows detection of characteristic attributes that deﬁne
subgroups. Private characteristic attributes will be
identiﬁed even if they exist only in a small percentage of
members of a group. Thus, if multiple subtypes of
cancer exist in a predeﬁned category, then CAOS would
detect each of their characteristic gene expression pat-
terns as private characteristic attributes. Such charac-
teristic attributes would be missed by techniques that
depend on overall similarity or on uniformity of gene
expression within a group.
Fourth, CAOS has the potential to identify charac-
teristic gene expression patterns that have relevance to
cancer. Pure characteristic attributes might represent
genes that are speciﬁcally induced or repressed. Private
characteristic attributes may represent genes that are
induced or expressed in a cancer subtype. Alternatively,
they may represent genes of the cancer group that are
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freed from a regulatory constraint. Compound charac-
teristic attributes have the potential to identify genes that
are interacting or co-regulated in certain types of cancer.
CAOS therefore has the potential to indicate regulatory
cascades and important multigene interactions.
4.3. Biological relevance of characteristic attributes
Conclusions about the biological relevance of speciﬁc
gene expression patterns identiﬁed within large data-
bases must be drawn with caution. The correlation of a
gene expression attribute with a speciﬁc category may
be a byproduct of the laboratory isolation technique,
the bioinformatic approach, sample contamination, or
simple chance. For example, CD45, a marker for leu-
kocytes such as colonic mucosa-associated T-cells, is
found by CAOS to be expressed at relatively higher
levels in a small subset of colon cancer specimens in the
Alon et al. data set. This may represent a true biologic
process or contamination of lymph tissue in some bi-
opsy specimens. Nevertheless, in each of the three data
sets analyzed, CAOS readily found genes with charac-
teristic expression attributes, many of which are known
or suspected to be important in speciﬁc disease pro-
cesses.
CAOS highlighted some genes not emphasized by
other analyses of the same data sets (Fig. 5). One fun-
damental reason for this diﬀerence is that CAOS re-
quires each characteristic attribute to unambiguously
classify every sample in which it appears. CAOS will
only identify genes that have expression states unique to
one group. Thus, CAOS also detects characteristic gene
expression states that only occur in a fraction of the cells
in a particular class. As a result, CAOS is able to dif-
ferentiate between characteristic and ambiguous ex-
pression patterns even if only a small number of cells
have a diﬀerent expression state.
Bittner et al. [7] used multidimensional scaling plots
to identify genes that diﬀerentiated between two clusters
of biopsied melanomas, referred to as major and minor.
This approach identiﬁed a subset of genes relating to cell
motility that was diﬀerentially expressed in the major
cluster of biopsy samples. Many of these genes were also
given high ranks by CAOS. Tenascin C, which ranked
12th (rank score of 4.2) by Bittner et al. and 18th (Rw
3.2) by CAOS has increased expression in some malig-
nant melanomas and may aﬀect cell motility [45]. Ann-
exin II and MART-1 were both among the top 20 genes
ranked by Bittner et al. and ranked highly by CAOS as
private characteristic attributes of the minor cluster of
biopsy samples. MART-1 is expressed in the majority of
melanomas and Annexin II appears to play a role in
immune response to melanomas [29,51].
CAOS also identiﬁed several genes whose products
are known to be important in melanoma biology but
were not given high priority in the Bittner et al. analysis.
For example, interleukin 6 (IL-6) is secreted by meta-
static melanoma cells [13], and it has been shown to
support autocrine or paracrine growth [33]. Serum IL-6
has been associated with disease progression and de-
creased survival [13]. CAOS found that lower expression
of IL-6 was a private characteristic attribute of the
major cluster. IL-6 ranks 30th (Rw 4.2) by CAOS and
was ranked as the 173rd (score 0.99) gene by Bittner
et al.
Another example is the human neural cell adhesion
molecule (hNCAM) whose gene has characteristic ex-
pression in the minor cluster and was ranked 31st (Rw
4.2) by CAOS and 174th (score 0.99) by Bittner et al.
Tumor cell adhesion molecules are known to be asso-
ciated with development of metastatic behavior in mel-
anoma [25]. Speciﬁcally, hNCAM is highly expressed in
aggressive uveal melanomas [32].
CAOS identiﬁed some genes with a potential role in
melanoma. The gene that ranks ﬁrst (Rw 7.5) in the
CAOS analysis and ranked 40th (score 1.3) by Bittner
et al. encodes inositol polyphosphate-4-phosphatase,
type II (4-Ptase II). This gene is expressed as a private
characteristic attribute in the minor cluster. Inositol
phospholipids may play an important role in cell signal
transduction. A closely related protein, 4-Ptase I, has
been shown to play a role in GATA-1 transcription
factor regulation [48]. Another example is DGCR6,
which has a role in cell migration and motility in the
neuronal crest cells [14] the progenitors of melanocytes.
The DGCR6 gene is ranked 26 (Rw 4.2) by CAOS and
142nd (score 1.1) in Bittners analysis.
Golub et al. [23], used a statistical method that ranked
a genes importance in distinguishing between AML and
ALL based on its correlation with idealized expression
patterns (neighborhood analysis) and noted that many
of the high ranking genes are important in leukemia bi-
ology. CAOS also identiﬁed genes for several markers of
leukemia lineage, including expression of Ig Dxp heavy
chain (a portion of the immunoglobulin heavy chain,
IgH) and CD9. IgH clonal rearrangement is character-
istic of ALL and it can be found in AML, where it may
indicate a poor prognosis [27]. CD9, found in 90% of B-
lineage ALL, is also expressed in acute promyelocytic
leukemia [24], and acute basophilic leukemia [15].
Other gene expression patterns found to distinguish
between ALL and AML may give insight into the biol-
ogy of leukemia. The interferon a-21 gene was expressed
at a higher level in a subset of ALL samples as compared
to AML samples. This may mean that interferon a-21
gene expression is constrained in all AML samples, but
not all ALL samples. Interferon a (INF-a) induces cell
cycle arrest and apoptosis in chronic myelogenous leu-
kemia (CML) [47]. The constrained expression of the
INF-a gene in AML as compared to ALL may indicate
that INF-a plays a role in the AML as well as CML.
Conversely, the gene for prostaglandin Ep3 Receptor,
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Alt. Splice 8 was expressed at a lower level in a subset of
ALL samples. The E-series prostaglandins are regulators
of B lymphocyte function and have been shown to in-
hibit growth in some B lymphoma cell lines [18,35].
CAOS also highlighted genes of interest relating to
the T-cell/B-cell distinction in ALL. C-yes-1 was ex-
pressed at a lower level in some B-cell samples relative to
T-cell samples. C-yes-1 is a proto-oncogene mapped to
the same chromosome band as bcl-2 (18q21.3) [34], and
is expressed in canine lymphoid neoplasm [31]. Several
genes for cell adhesion molecules such as Cadherin-6
and cellular adhesion regulatory molecule (CMAR), as
well as several known tryosine kinases, were also found
to be expressed as private characteristic attributes in T
or B cell ALL.
CAOS-based analysis of the Alon et al. [2] data set
revealed several genes with established roles in colon
cancer. The P-cadherin gene is expressed at a higher
level in a portion of the colon cancer samples. Cadherins
are a family of cell-to-cell adhesion molecules known to
play an important role in many solid tumors including
colon, prostate, breast, and lung cancer. P-cadherin up-
regulation may represent early neoplastic transforma-
tion in glandular mucosa and adenomatous polyps [40].
Protein kinase C-f type (PKC-f) has characteristic
expression in the colon cancer category. The PKC family
of isoenzymes plays an important role in cell signaling
and tumor promotion [8]. The PKC-f gene is expressed
in azoxymethane-induced tumors treated with nonste-
roidal anti-inﬂammatory drugs in trials using animal
tumor models [39]. Other genes highlighted by CAOS in
the colon cancer samples include those for HMG-1,
which is expressed in gastric and colorectal adenocarci-
noma [49], and several tryosine and serine–threonine
protein kinases with as yet poorly deﬁned roles in cancer.
5. Signiﬁcance and future prospects
The results show that CAOS has considerable
promise as a new method for microarray analysis and
has the potential to identify relevant genes missed by
other types of analysis. Even in this simple form, CAOS
is a highly accurate method for classiﬁcation. Because
the sensitivity and speciﬁcity of CAOS-based diagnosis
increases with more information, the use of even larger
data sets will allow CAOS to identify diagnostic rules
that far outperform those used in this study. Addition-
ally, representation of the data by more than two dis-
crete bins may reveal further expression patterns. By
using just two bins, we may have obscured informative
gene patterns by missing more subtle expression patterns
beyond just on or oﬀ. It is our hope that this pre-
liminary examination of the potential of the CAOS al-
gorithm for basic research and clinical diagnosis will
stimulate further reﬁnement and development.
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